Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
IKT holding history
Inhibikase Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IKT overviewAll 13F holders of IKTFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −16,500−100.0% | Sold out | Holders |
| Q1 2026 | 16,500 | $27.7K | <0.1% | +16,500 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −19,922−100.0% | Sold out | Holders |
| Q3 2024 | 19,922 | $25.9K | <0.1% | −900−4.3% | Reduced | Holders |
| Q2 2024 | 20,822 | $25.2K | <0.1% | −600−2.8% | Reduced | Holders |
| Q1 2024 | 21,422 | $46.0K | <0.1% | −3,000−12.3% | Reduced | Holders |
| Q4 2023 | 24,422 | $31.0K | <0.1% | +8,300+51.5% | Added | Holders |
| Q3 2023 | 16,122 | $22.0K | <0.1% | +3,400+26.7% | Added | Holders |
| Q2 2023 | 12,722 | $46.0K | <0.1% | +1,505+13.4% | AddedConverted for a 1-for-6 split | Holders |
| Q1 2023 | 67,300 | $44.0K | <0.1% | +15,300+29.4% | Added | Holders |
| Q4 2022 | 52,000 | $26.0K | <0.1% | −72,683−58.3% | Reduced | Holders |
| Q3 2022 | 124,683 | $113.0K | <0.1% | −97,217−43.8% | Reduced | Holders |
| Q2 2022 | 221,900 | $165.0K | <0.1% | +33,431+17.7% | Added | Holders |
| Q1 2022 | 188,469 | $279.0K | <0.1% | −12,731−6.3% | Reduced | Holders |
| Q4 2021 | 201,200 | $296.0K | <0.1% | +201,200 | New | Holders |